Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans

Henning Tim Langer, Natalie K. Gilmore, Chris M. T. Hayden, Julien Roux, Bruno Bariohay, Thaïs Rhouquet, Manar Awada, Julie Marcotorchino, Lorrine Bournot, Elizabeth Nunn, Paul M. Titchenell, Daniela Liskiewicz, Timo D. Müller, Oluwaseun Anyiam, Philip J. Atherton, Iskandar Idris, Natalia Haritonow, Kristina Norman, Ursula Müller-Werdan, Keith Baar

Open source

DOI: 10.1101/2025.07.28.25332295
Published: 2025-07-28
Container: Not recorded
Publisher: openRxiv
Open access: unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
cautionPublication version: Identified as a preprint; peer review and later versions may change the record. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1101/2025.07.28.25332295,
  title = {Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans},
  author = {Henning Tim Langer and Natalie K. Gilmore and Chris M. T. Hayden and Julien Roux and Bruno Bariohay and Thaïs Rhouquet and Manar Awada and Julie Marcotorchino and Lorrine Bournot and Elizabeth Nunn and Paul M. Titchenell and Daniela Liskiewicz and Timo D. Müller and Oluwaseun Anyiam and Philip J. Atherton and Iskandar Idris and Natalia Haritonow and Kristina Norman and Ursula Müller-Werdan and Keith Baar},
  year = {2025},
  doi = {10.1101/2025.07.28.25332295},
  url = {https://doi.org/10.1101/2025.07.28.25332295}
}

RIS

TY  - JOUR
TI  - Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans
AU  - Henning Tim Langer
AU  - Natalie K. Gilmore
AU  - Chris M. T. Hayden
AU  - Julien Roux
AU  - Bruno Bariohay
AU  - Thaïs Rhouquet
AU  - Manar Awada
AU  - Julie Marcotorchino
AU  - Lorrine Bournot
AU  - Elizabeth Nunn
AU  - Paul M. Titchenell
AU  - Daniela Liskiewicz
AU  - Timo D. Müller
AU  - Oluwaseun Anyiam
AU  - Philip J. Atherton
AU  - Iskandar Idris
AU  - Natalia Haritonow
AU  - Kristina Norman
AU  - Ursula Müller-Werdan
AU  - Keith Baar
PY  - 2025
DO  - 10.1101/2025.07.28.25332295
UR  - https://doi.org/10.1101/2025.07.28.25332295
ER  -

APA

Langer, H. T., Gilmore, N. K., Hayden, C. M. T., Roux, J., Bariohay, B., Rhouquet, T., Awada, M., Marcotorchino, J., Bournot, L., Nunn, E., Titchenell, P. M., Liskiewicz, D., Müller, T. D., Anyiam, O., Atherton, P. J., Idris, I., Haritonow, N., Norman, K., Müller-Werdan, U., & Baar, K. (2025). Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans. https://doi.org/10.1101/2025.07.28.25332295

Source records

crossref · retrieved 2026-09-26T15:51:32.927Z